Skip to main content
John Teerlink, MD, Cardiology, San Francisco, CA, San Francisco VA Medical Center

JohnRTeerlinkMD

Cardiology San Francisco, CA

Professor, Medicine, UCSF School of Medicine; Director, Heart Failure and Director, Echocardiography, SFVAMC

Dr. Teerlink is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Teerlink's full profile

Already have an account?

  • Office

    4150 Clement St
    Sfvamc; Cardiology 111c
    San Francisco, CA 94121
    Phone+1 415-750-2112
    Fax+1 415-750-6950
  • Is this information wrong?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Cardiovascular Disease, 1991 - 1995
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1988 - 1991
  • Harvard Medical School
    Harvard Medical SchoolClass of 1988
  • Swarthmore College
    Swarthmore CollegeBA, Religion/ Cell Biology, Highest Honors in Honors program, 1979 - 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1990 - 2025

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure  
    John R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
  • Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial  
    John R Teerlink, Ronald S Freudenberger, Arthur J Labovitz, Shunichi Homma, Siqin Ye, Journal of Cardiac Failure
  • Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure  
    Javed Butler, John R Teerlink, Lukasz P Cerbin, Adam D DeVore, Randall C Starling, Adrian F Hernandez, Robert J Mentz, ScienceDirect
  • Join now to see all

Lectures

  • Effect of Omecamtiv Mecarbil in Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction: Results From COSMIC-HF 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Hemodynamics in Heart Failure: Understanding the Fundamentals 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Drug Therapies in Acute Heart Failure: The Old and New, What Works and What Doesn't? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
  • Join now to see all

Authored Content

  • Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF TrialAugust 2018
  • Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart FailureMarch 2018
  • Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart FailureMarch 2018
  • Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart FailureMarch 2018
  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
  • Join now to see all

Press Mentions

  • Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
    Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional DataMay 30th, 2022
  • Cytokinetics Announces Additional Results from GALACTIC-HF Presented at American Heart Association Scientific Sessions 2021
    Cytokinetics Announces Additional Results from GALACTIC-HF Presented at American Heart Association Scientific Sessions 2021November 15th, 2021
  • Cytokinetics Announces Secondary Analysis of GALACTIC-HF Presented in Late Breaking Clinical Trial Session at the American College of Cardiology 70th Annual Scientific Session and Published in the Journal of American College of Cardiology
    Cytokinetics Announces Secondary Analysis of GALACTIC-HF Presented in Late Breaking Clinical Trial Session at the American College of Cardiology 70th Annual Scientific Session and Published in the Journal of American College of CardiologyMay 17th, 2021
  • Join now to see all

Grant Support

  • Core--Hemodynamics LaboratoryNational Heart, Lung, And Blood Institute2002–2005

Professional Memberships

Hospital Affiliations